View Grant Opportunity

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

National Institutes of Health

PAR-25-110

HHS-NIH11

General Information

N/a
Est. Program Funding:
May 7, 2026
Closing Date:
N/a
Expected No. of Awards
N/a
Award Ceiling

Opportunity Number:
PAR-25-110

Owning Agency:
HHS-NIH11

Opportunity Category:
Discretionary (D)

Synopsis

The purpose of this notice of funding opportunity (NOFO) is to support translational and clinical research to (1) advance precision medicine in pregnant women, lactating women, and children through the development of novel tools, models, and other technologies that could have a direct clinical or health impact; (2) enhance the understanding of the underlying mechanisms of drug action, including the role of pediatric ontogeny and the dynamic physiological changes that occur during pregnancy and lactation; and (3) discover and develop novel therapeutics or enhance the usage of existing drugs or drug repurposing for safer and more effective medications in pregnant and lactating women, neonates, and children. The overall goal is to improve safe and effective precision therapeutics for pregnant and lactating women, fetuses, neonates, and children, including those with disabilities.

Response Date May 07, 2026 12:00:00 AM EDT
Posting Date Nov 18, 2024 12:00:00 AM EST
Archive Date Jun 12, 2026 12:00:00 AM EDT
Award Ceiling N/a
Award Floor N/a
Cost Sharing No

Eligibility

Eligible Applicants County governments, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Native American tribal organizations (other than Federally recognized tribal governments), Public housing authorities/Indian housing authorities, Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Special district governments, Native American tribal governments (Federally recognized), Small businesses, Public and State controlled institutions of higher education, Others (see text field entitled "Additional Information on Eligibility" for clarification), State governments, City or township governments, Independent school districts
Additional Info on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name National Institutes of Health
Link to Additional Information: https://grants.nih.gov/grants/guide/pa-files/PAR-25-110.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact: GrantSolutions Help Desk
Phone: 301-402-2541

CFDA Program(s)

  • 93.242: Mental Health Research Grants
  • 93.279: Drug Use and Addiction Research Programs
  • 93.313: NIH Office of Research on Women's Health
  • 93.855: Allergy and Infectious Diseases Research
  • 93.865: Child Health and Human Development Extramural Research
   

Contact Us



Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.

×

Request Grant Writing Assistance from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.